Mason Morfit

From Wikipedia, the free encyclopedia
Jump to: navigation, search

G. Mason Morfit is CFA and president of ValueAct Capital. He was appointed on Board of Directors of Microsoft in March-2014. [1] [2]


Morfit has B.A. from Princeton University and he is a CFA charterholder.


Morfit joined the ValueAct Capital in January 2001. Prior to that he worked in equity research for Credit Suisse First Boston. Morfit is a director of Valeant Pharmaceuticals International and a former director of Advanced Medical Optics, Inc., C.R. Bard, Inc., Immucor, Inc., MSD Performance, Inc. and Solexa, Inc. [3]